Skip to main content
Clinical Trials/ACTRN12614001280695
ACTRN12614001280695
Not yet recruiting
未知

A pilot study assessing the use of intra-operative, patient-controlled sedation with midazolam and fentanyl for patients undergoing insertion of a central venous line.

Alfred Hospital0 sites10 target enrollmentDecember 5, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Radiologically-guided insertion of a central venous line for patients undergoing chemotherapy, dialysis, or other conditions requiring high flow long term central line access (eg treatment of cystic fibrosis or other chronic disease)
Sponsor
Alfred Hospital
Enrollment
10
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 5, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Alfred Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients referred to the Radiology Department for elective central venous line insertion (for example, but not limited to: Hickman line for chemotherapy or antibiotics, Portacath for commencement urgent dailysis)
  • Males and females aged 18 to 75
  • No allergy to fentanyl and/or midazolam
  • ASA score 1 to 3
  • Signed study participant information and Consent form.

Exclusion Criteria

  • Coagulopathy (INR \> 2, platelets \< 50\)
  • Abnormal renal function with a calculated e\-GFR \<40;
  • Allergy to contrast;
  • ASA score 4 to 6
  • Therapeutic heparinisation or current thrombolysis
  • Cellulitis or dermatitis at planned insertion site
  • On protease inhibitor antiretroviral drugs
  • Altered conscious state
  • Head injury
  • Significant hepatic dysfunction

Outcomes

Primary Outcomes

Not specified

Similar Trials